Group One Trading’s ProPhase Labs PRPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-27,300
Closed -$12.2K 8508
2025
Q4
$12.2K Buy
27,300
+24,760
+975% +$69.7K ﹤0.01% 6690
2025
Q3
$11.6K Buy
2,540
+2,110
+491% +$8.16K ﹤0.01% 7082
2025
Q2
$1.68K Buy
+430
New +$1.44K ﹤0.01% 7453
2024
Q3
Sell
-20
Closed -$836 7215
2024
Q2
$836 Hold
20
﹤0.01% 6394
2024
Q1
$1.29K Sell
20
-20
-50% -$1.01K ﹤0.01% 6580
2023
Q4
$1.81K Sell
40
-970
-96% -$44.2K ﹤0.01% 6854
2023
Q3
$44.1K Sell
1,010
-60
-6% -$3.51K ﹤0.01% 5215
2023
Q2
$77.7K Buy
1,070
+140
+15% +$11.4K ﹤0.01% 4872
2023
Q1
$70.9K Buy
+930
New +$75K ﹤0.01% 4575
2022
Q1
Sell
-470
Closed -$34K 8539
2021
Q4
$34K Buy
470
+410
+683% +$25.5K ﹤0.01% 6618
2021
Q3
$3K Sell
60
-1,620
-96% -$96.5K ﹤0.01% 7881
2021
Q2
$104K Buy
+1,680
New +$94.4K ﹤0.01% 5909

Other funds holding PRPH

Group One Trading's PRPH Position: Q3 2024 in Review

Group One Trading sold out of ProPhase Labs (PRPH) in Q3 2024, closing a stake of 71 shares — an estimated $2.95K sold.

Group One Trading first reported a position in PRPH in Q4 2021 and held it in 5 quarters. The position peaked at $35K in Q1 2022. 27 funds tracked by Wall St. Rank hold PRPH as of Q3 2024.

  • Group One Trading reported no remaining ProPhase Labs position as of Q3 2024 after selling out during the quarter.
  • Group One Trading sold 71 ProPhase Labs shares in Q3 2024, an estimated $2.95K.
  • Group One Trading first reported a position in ProPhase Labs in Q4 2021 and held it in 5 quarters.
  • Group One Trading's ProPhase Labs position peaked at $35K in Q1 2022.
  • 27 funds tracked by Wall St. Rank held ProPhase Labs as of Q3 2024.

Based on Group One Trading's 13F filing for Q3 2024, filed 14 Nov 2024.